Post Profile

Dealmaking is off to a scorching start — and one Wall Street CEO says it could just be getting started

Dealmaking is off to a hot start in 2018, with nearly $225 billion in mergers-and-acquisitions volume in January. Several ingredients are present that could keep M&A humming along, according to Lazard CEO Ken Jacobs. "Confidence levels in the boardrooms among CEOs is as good as I've seen it for a long time," Jacobs told Business Insider Wall Street firms expected a hot start for mergers and acquisitions in 2018, and that's exactly what unfolded in January.
read more


Related Posts

A star Wall Street dealmaker has made a killing on the $130 billion Dow-DuPont deal (DOW)

Business & Finance : Business Insider: Money Game

A star Wall Street dealmaker just bagged a multi-million dollar payday on the $130 billion merger of Dow Chemical and DuPont. Michael Klein, who runs Klein & Company, a small boutique advisory firm, is advising Dow Chemical on the d...

Here's how much the top Wall Street banks have earned in fees this year

Business & Finance : Business Insider: Clusterstock

It has been a miserable start to the year for Wall Street dealmakers. Revenues from equity and debt deals and mergers and acquisitions have fallen off a cliff. Industry-wide global investment banking revenue is down 36% from the fir...

Mergers and Acquisitions Boom! Is This a Good Sign for the Economy?

Business & Finance : The Curious Capitalist

Wall Street dealmakers are off to a busy start to 2013, as some of corporate America’s most recognizable names have become involved in multi-billion-dollar mergers and acquisitions. Just yesterday, American Airlines and US Airways a...

A veteran Wall Street dealmaker is retiring from Goldman Sachs

Business & Finance : Business Insider: Clusterstock

A veteran Wall Street dealmaker is bowing out. Goldman Sachs' head of cross-border mergers and acquisitions, James Del Favero, is retiring from the firm after nearly three decades. Del Favero joined Goldman Sachs' mergers-and-acquis...

WALL STREET PAYDAY: 4 banks made a killing from Monday's $20 billion in biotech deals

Business & Finance : Business Insider: Clusterstock

Biotech mergers and acquisitions are off to a hot start in 2018. On Monday, French drugmaker Sanofi spent $11.6 billion to buy US hemophilia firm Bioverativ, and Celgene spent $9 billion on cancer specialist Juno Therapeutics. Inves...


Copyright © 2016 Regator, LLC